| Title | Journal of Leukemia and Lymphoma |
| Abbreviation | J. Leuk. Lymphoma |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q4); Hematology (Q4); Oncology (Q4) |
| h-index | 5 |
| Overall Rank/Ranking | 28225 |
| SCImago Journal Rank (SJR) | 0.101 |
| Impact Score | 0.02 |
| Publisher | Chinese Medical Journals Publishing House Co.Ltd |
| Country | China |
| ISSN | 10099921 |
| Best Quartile | Q4 |
| Coverage History | 2008-2023 |
Journal of Leukemia and Lymphoma is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Hematology (Q4); Oncology (Q4). It is published by Chinese Medical Journals Publishing House Co.Ltd. The overall rank of Journal of Leukemia and Lymphoma is 28225. According to SCImago Journal Rank (SJR), this journal is ranked 0.101. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 5. The best quartile for this journal is Q4.
The ISSN of Journal of Leukemia and Lymphoma journal is 10099921. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Leukemia and Lymphoma is cited by a total of 8 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal of Leukemia and Lymphoma is 0.02, which is computed in 2024 as per its definition. Journal of Leukemia and Lymphoma IF is decreased by a factor of 0.01 and approximate percentage change is -33.33% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal of Leukemia and Lymphoma is 0.02. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.02 |
| 2022 | 0.03 |
| 2021 | 0.03 |
| 2020 | 0.12 |
| 2019 | 0.10 |
| 2018 | 0.36 |
| 2017 | 0.13 |
| 2016 | 0.16 |
| 2015 | 0.01 |
| 2014 | 0.01 |
Journal of Leukemia and Lymphoma has an h-index of 5. It means 5 articles of this journal have more than 5 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Leukemia and Lymphoma is 10099921. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Leukemia and Lymphoma is 28225. According to SCImago Journal Rank (SJR), this journal is ranked 0.101. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.101 |
| 2022 | 0.101 |
| 2021 | 0.105 |
| 2020 | 0.109 |
| 2019 | 0.184 |
| 2018 | 0.142 |
| 2017 | 0.113 |
| 2016 | 0.112 |
| 2015 | 0.102 |
| 2014 | 0.101 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 28225 |
| 2022 | 27041 |
| 2021 | 24966 |
| 2020 | 28816 |
| 2019 | 19495 |
| 2018 | 22171 |
| 2017 | 26573 |
| 2016 | 26673 |
| 2015 | 29059 |
| 2014 | 29485 |
Journal of Leukemia and Lymphoma is published by Chinese Medical Journals Publishing House Co.Ltd. It's publishing house is located in China. Coverage history of this journal is as following: 2008-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Leukemia and Lymphoma is J. Leuk. Lymphoma. This abbreviation ('J. Leuk. Lymphoma') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q4); Hematology (Q4); Oncology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Leukemia and Lymphoma latest impact IF is 0.02. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 0.36 (2018) and 0.01 (2015), respectively, in the last 10 years. Moreover, its average IS is 0.1 in the previous 10 years.
The Journal of Leukemia and Lymphoma has an SJR (SCImago Journal Rank) of 0.101, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.184 in 2019 and the lowest being 0.101 in 2023. Furthermore, the average SJR of the Journal of Leukemia and Lymphoma over the previous 10-year period stands at 0.1.
The latest h-index of the Journal of Leukemia and Lymphoma is 5.
The Journal of Leukemia and Lymphoma is published by the Chinese Medical Journals Publishing House Co.Ltd, with its country of publication being the China.
The Journal of Leukemia and Lymphoma is currently ranked 28225 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 19495 in 2019 and its lowest position of 29485 in 2014.
The standard ISO4 abbreviation for the Journal of Leukemia and Lymphoma is J. Leuk. Lymphoma.
Journal of Leukemia and Lymphoma is classified as a journal that the Chinese Medical Journals Publishing House Co.Ltd publishes.
The Journal of Leukemia and Lymphoma encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Leukemia and Lymphoma is assigned the following International Standard Serial Numbers (ISSN): 10099921.
The best quartile for the Journal of Leukemia and Lymphoma is Q4 (2023).
The Journal of Leukemia and Lymphoma coverage history can be summarized as follows: 2008-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Entrepreneurship Theory and Practice | journal | 220 | Wiley-Blackwell | 198 | 15.69 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 27272 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Built Environment | journal | 12809 | Alexandrine Press | 46 | 1.18 |
| Journal des Professionnels de l'Enfance | journal | 28748 | TPMA | 2 | 0.00 |
| European Journal of Cancer, Supplement | journal | 6710 | Elsevier Ltd | 29 | 0.33 |
| Acta Literaria | journal | 27930 | Universidad de Concepcion | 6 | 0.03 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 0.02 |
| 2022 | 0.03 |
| 2021 | 0.03 |
| 2020 | 0.12 |
| 2019 | 0.10 |
| 2018 | 0.36 |
| 2017 | 0.13 |
| 2016 | 0.16 |
| 2015 | 0.01 |
| 2014 | 0.01 |
